Published • loading... • Updated
Wegovy Weight-Loss Pills Go on Sale in UK Pharmacies
Private pharmacies are selling the first oral Wegovy tablets for £79 a month, while NHS access may not come until 2028, experts said.
- Wegovy oral weight-loss tablets launched in UK pharmacies on Monday, marking the first time the medication is available in pill form to patients seeking private treatment.
- The Medicines and Healthcare products Regulatory Agency approved the tablet last month, providing an "oral alternative" for patients who find self-injecting jabs a barrier to treatment.
- Patients can obtain the medication starting from £79 per month, requiring daily administration on an empty stomach with a sip of water after an eight-hour fast.
- Pharmacies warn of increased black market risks; 97 per cent of surveyed chemists expressed concern that the pill format is easier for criminals to counterfeit than injections.
- While currently limited to private sales, availability on the National Health Service remains pending until the National Institute for Health and Care Excellence approves the treatment; experts suggest 2027 or 2028.
Insights by Ground AI
37 Articles
37 Articles
Following the global sensation caused by weight-loss injections, a new weight-loss pill containing the same active ingredient has been officially launched in the United Kingdom. While health organizations have endorsed the pill's effectiveness, 97% of pharmacists warn of the dangers of counterfeit drugs and the black market.
·Istanbul, Türkiye
Read Full Article
Wegovy weight loss pill on sale in UK this week - what you could lose
The Wegovy weight loss pill is now available to buy in the UK, offering patients access to GLP-1 semaglutide medication without the need for weekly injections - here is what you need to know about cost and results
·Nottingham, United Kingdom
Read Full ArticleCoverage Details
Total News Sources37
Leaning Left8Leaning Right2Center20Last UpdatedBias Distribution66% Center
Bias Distribution
- 66% of the sources are Center
66% Center
L 27%
C 66%
Factuality
To view factuality data please Upgrade to Premium
